PGEN:NASDAQ
Precigen Inc
$7.10
arrow_downward
-0.56%(-0.040) 1D
$7.07
arrow_downward
-0.42% (-0.030)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.12
High
$7.27
Low
$7.08
Mkt. cap
2.54B
Avg. vol.
5.50M
Volume
2.19M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
Open
$7.12
High
$7.27
Low
$7.08
Mkt. cap
2.54B
Avg. vol.
5.50M
Volume
2.19M
52-wk high
$7.72
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
Precigen CFO Sells $1.1 Million in Shares – What It Could Mean for Investors - Earnings Revision Report
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com